The content creator, 26, was diagnosed with a rare bile duct cancer nearly three years ago ...

A phase 2/3 trial evaluates the efficacy and safety of neoadjuvant therapy with gemcitabine-oxaliplatin, lenvatinib, and ...

Incidental detection has increased with ubiquitous CT/MRI, inflating early-stage ‘small renal mass’ diagnoses and complicating interpretation of a ~5% rise in <50-year incidence. Obesity, hypertension ...

Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven ...

Dan Milsten, a former UW football player and Tacoma native, has undergone a difficult three-month ordeal after being ...

Adding the immune checkpoint inhibitors (ICIs) ipilimumab and nivolumab to percutaneous hepatic perfusion may improve survival outcomes in patients with ...

Cancer death rates in the UK have hit a historic new low, according to data. The charity Cancer Research UK, which analysed ...

GSK will receive $300 million upfront from Alfasigma for linerixibat, plus $100 million upon anticipated FDA approval and additional regulatory and sales-based milestones with tiered double-digit ...

Cancer Research UK data shows death rates have fallen 11% in the last decade overall with significant falls in cancers such as breast cancer and cervical cancer ...

Transmission electron micrograph showing hepatitis B virus particles (colored orange). The Johns Hopkins Medicine-led ...